CRISPR in Europe: the patent landscape for 2018

30-11-2017

CRISPR in Europe: the patent landscape for 2018

ralwel / iStockphoto.com

The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR.


Broad Institute of MIT and Harvard, CRISPR/Cas9, gene editing, patent, European patent, patent claims,

LSIPR